295 related articles for article (PubMed ID: 10357135)
1. Potential of porous poly-D,L-lactide-co-glycolide particles as a carrier for recombinant human bone morphogenetic protein-2 during osteoinduction in vivo.
Boyan BD; Lohmann CH; Somers A; Niederauer GG; Wozney JM; Dean DD; Carnes DL; Schwartz Z
J Biomed Mater Res; 1999 Jul; 46(1):51-9. PubMed ID: 10357135
[TBL] [Abstract][Full Text] [Related]
2. Addition of human recombinant bone morphogenetic protein-2 to inactive commercial human demineralized freeze-dried bone allograft makes an effective composite bone inductive implant material.
Schwartz Z; Somers A; Mellonig JT; Carnes DL; Wozney JM; Dean DD; Cochran DL; Boyan BD
J Periodontol; 1998 Dec; 69(12):1337-45. PubMed ID: 9926763
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery system for juxtacrine signaling growth factor based on rhBMP-2-mediated carrier-protein conjugation.
Liu HW; Chen CH; Tsai CL; Hsiue GH
Bone; 2006 Oct; 39(4):825-36. PubMed ID: 16782421
[TBL] [Abstract][Full Text] [Related]
4. Biodegradable poly-D,L-lactic acid-polyethylene glycol block copolymers as a BMP delivery system for inducing bone.
Saito N; Okada T; Horiuchi H; Murakami N; Takahashi J; Nawata M; Ota H; Miyamoto S; Nozaki K; Takaoka K
J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S92-8. PubMed ID: 11314801
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human bone morphogenetic protein-2 binding and incorporation in PLGA microsphere delivery systems.
Schrier JA; DeLuca PP
Pharm Dev Technol; 1999; 4(4):611-21. PubMed ID: 10578516
[TBL] [Abstract][Full Text] [Related]
6. Interaction of recombinant human bone morphogenetic protein-2 with poly(d,l lactide-co-glycolide) microspheres.
Duggirala SS; Mehta RC; DeLuca PP
Pharm Dev Technol; 1996 Apr; 1(1):11-9. PubMed ID: 9552326
[TBL] [Abstract][Full Text] [Related]
7. Long-term stability of bone tissues induced by an osteoinductive biomaterial, recombinant human bone morphogenetic protein-2 and a biodegradable carrier.
Kokubo S; Mochizuki M; Fukushima S; Ito T; Nozaki K; Iwai T; Takahashi K; Yokota S; Miyata K; Sasaki N
Biomaterials; 2004 May; 25(10):1795-803. PubMed ID: 14738843
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of 2 novel approaches for assessing the ability of demineralized freeze-dried bone allograft to induce new bone formation.
Carnes DL; De La Fontaine J; Cochran DL; Mellonig JT; Keogh B; Harris SE; Ghosh-Choudhury N; Dean DD; Boyan BD; Schwartz Z
J Periodontol; 1999 Apr; 70(4):353-63. PubMed ID: 10328645
[TBL] [Abstract][Full Text] [Related]
9. Bone regeneration produced in rat femur defects by polymer capsules containing recombinant human bone morphogenetic protein-2.
Isobe M; Yamazaki Y; Mori M; Amagasa T
J Oral Maxillofac Surg; 1999 Jun; 57(6):695-8; discussion 699. PubMed ID: 10368095
[TBL] [Abstract][Full Text] [Related]
10. The effect of rhBMP-2 around endosseous implants with and without membranes in the canine model.
Jones AA; Buser D; Schenk R; Wozney J; Cochran DL
J Periodontol; 2006 Jul; 77(7):1184-93. PubMed ID: 16805681
[TBL] [Abstract][Full Text] [Related]
11. Radiographic analysis of regenerated bone around endosseous implants in the canine using recombinant human bone morphogenetic protein-2.
Cochran DL; Nummikoski PV; Jones AA; Makins SR; Turek TJ; Buser D
Int J Oral Maxillofac Implants; 1997; 12(6):739-48. PubMed ID: 9425754
[TBL] [Abstract][Full Text] [Related]
12. Ectopic induction of cartilage and bone by bovine bone morphogenetic protein using a biodegradable polymeric reservoir.
Yamazaki Y; Oida S; Ishihara K; Nakabayashi N
J Biomed Mater Res; 1996 Jan; 30(1):1-4. PubMed ID: 8788099
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment with platelet derived growth factor-BB modulates the ability of costochondral resting zone chondrocytes incorporated into PLA/PGA scaffolds to form new cartilage in vivo.
Lohmann CH; Schwartz Z; Niederauer GG; Carnes DL; Dean DD; Boyan BD
Biomaterials; 2000 Jan; 21(1):49-61. PubMed ID: 10619678
[TBL] [Abstract][Full Text] [Related]
14. Ectopic bone formation in mice associated with a lactic acid/dioxanone/ethylene glycol copolymer-tricalcium phosphate composite with added recombinant human bone morphogenetic protein-2.
Kato M; Namikawa T; Terai H; Hoshino M; Miyamoto S; Takaoka K
Biomaterials; 2006 Jul; 27(21):3927-33. PubMed ID: 16564087
[TBL] [Abstract][Full Text] [Related]
15. Experimental studies on bone induction using low-molecular-weight poly (DL-lactide-co-glycolide) as a carrier for recombinant human bone morphogenetic protein-2.
Bessho K; Carnes DL; Cavin R; Ong JL
J Biomed Mater Res; 2002 Jul; 61(1):61-5. PubMed ID: 12001247
[TBL] [Abstract][Full Text] [Related]
16. A histological study on experimental tooth movement into bone induced by recombinant human bone morphogenetic protein-2 in beagle dogs.
Kawamoto T; Motohashi N; Kitamura A; Baba Y; Takahashi K; Suzuki S; Kuroda T
Cleft Palate Craniofac J; 2002 Jul; 39(4):439-48. PubMed ID: 12071792
[TBL] [Abstract][Full Text] [Related]
17. A study on a tissue-engineered bone using rhBMP-2 induced periosteal cells with a porous nano-hydroxyapatite/collagen/poly(L-lactic acid) scaffold.
Zhang C; Hu YY; Cui FZ; Zhang SM; Ruan DK
Biomed Mater; 2006 Jun; 1(2):56-62. PubMed ID: 18460757
[TBL] [Abstract][Full Text] [Related]
18. Modulation of anabolic and catabolic responses via a porous polymer scaffold manufactured using thermally induced phase separation.
Yu NY; Schindeler A; Peacock L; Mikulec K; Fitzpatrick J; Ruys AJ; Cooper-White JJ; Little DG
Eur Cell Mater; 2013 Feb; 25():190-203. PubMed ID: 23444237
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic protein but not transforming growth factor-beta enhances bone formation in canine diaphyseal nonunions implanted with a biodegradable composite polymer.
Heckman JD; Ehler W; Brooks BP; Aufdemorte TB; Lohmann CH; Morgan T; Boyan BD
J Bone Joint Surg Am; 1999 Dec; 81(12):1717-29. PubMed ID: 10608383
[TBL] [Abstract][Full Text] [Related]
20. Importance of delivery systems for growth-stimulatory factors in combination with osteopromotive membranes. An experimental study using rhBMP-2 in rat mandibular defects.
Zellin G; Linde A
J Biomed Mater Res; 1997 May; 35(2):181-90. PubMed ID: 9135167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
